CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. The rise in geriatric and obesity population
4.1.2. Increase in road accidents & sports injuries
4.1.3. Increasing preference for minimally invasive procedures
4.1.4. Growing occurrence of spinal disorders
4.2. Market Restraints & Challenges
4.2.1. Side effects associated with BMP-based treatments
4.2.2. Strict regulatory approval procedures & lack of clinical trial data
4.2.3. The high cost of procedures
4.3. Market Opportunities
4.3.1. Advancements in implant technologies
4.3.2. Growing demand for biological solutions
CHAPTER 5 GLOBAL ORTHOBIOLOGICS MARKET – BY PRODUCT
5.1. Viscosupplementation
5.2. Demineralized Bone Matrices
5.3. Synthetic Orthobiologics
5.4. Bone Morphogenic Protein
5.5. Bone Allografts
5.6. Plasma-Rich Protein
5.7. Bone Marrow Aspirate Concentrate
5.8. Stem Cell Therapy
5.9. Bone Graft Substitutes
5.10. Others
CHAPTER 6 GLOBAL ORTHOBIOLOGICS MARKET – BY APPLICATION
6.1. Osteoarthritis and Degenerative Arthritis
6.2. Spinal Fusion
6.3. Soft-Tissue Injuries
6.4. Fracture Recovery
6.5. Maxillofacial and Dental
CHAPTER 7 GLOBAL ORTHOBIOLOGICS MARKET – BY END USER
7.1. Hospitals, Orthopedic Clinics, & Ambulatory Care Centers
7.2. Research & Academic Institutes
7.3. Dental Clinics and Facilities
CHAPTER 8 GLOBAL ORTHOBIOLOGICS MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9 GLOBAL ORTHOBIOLOGICS MARKET - COMPANY PROFILES
9.1. Arthrex Inc.
9.2. Bioventus LLC
9.3. Depuy Synthes (A Subsidiary of Johnson & Johnson)
9.4. Globus Medical Inc.
9.5. Harvest Technologies Corporation (A Terumo Bct Company)
9.6. K2M Group Holdings Inc.
9.7. Kuros Biosciences Ltd
9.8. Medtronic PLC
9.9. Nuvasive Inc.
9.10. Orthofix International NV
9.11. RTI Surgical Inc.
9.12. Seaspine Holdings Corporation
9.13. Xtant Medical Holdings, Inc.
9.14. Zimmer Biomet Holdings, Inc.
9.15. Stryker Corporation
CHAPTER 10 GLOBAL ORTHOBIOLOGICS MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11 MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12 APPENDIX
12.1. List of Tables
12.2. List of Figures
